TILS.L Regulatory News (TILS)

30 Apr 2008 09:13

ReGen Therapeutics PLC30 April 2008 Immediate Release 30 April 2008 ReGen Therapeutics Plc ('ReGen' or the Company') Total Voting Rights For the purposes of the Disclosure and Transparency Rules of the FinancialServices Authority, the Board of ReGen is required to notify the market of thefollowing: As at the date of this announcement, the Company's issued share capital consistsof 11,482,452 ordinary shares with a nominal value of 10 p each, with votingrights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore the total number of Ordinary Shares in the Company with voting rightsis 11,482,452. The above figure of 11,482,452 Ordinary Shares may be used by shareholders inthe Company as the denominator for the calculations by which they willdetermine if they are required to notify their interest in, or a change to theirinterest in, the share capital of the Company under the Financial ServiceAuthority's Disclosure and Transparency Rules. ENDS For further information, please contact: Percy LomaxReGen Therapeutics PlcTel: 020 7153 4920 Roland Cornish/Felicity GeidtBeaumont Cornish LimitedTel: 020 7628 3396 David Scott/Nick BealerAlexander David Securities LimitedTel: 020 7448 9800 This information is provided by RNS The company news service from the London Stock Exchange